Ambrosia Bio
PrivateLast Round
Series A
Dec 10, 2024
Est. Valuation
$39.75M
Total Funding Raised
$25M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ambrosia Bio is a biotechnology company that offers an enzyme-based technology for producing allulose, a low-calorie sugar substitute.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ambrosia Bio Comparables
Compare Ambrosia Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bonumose, Inc. | 81% | |
| Prodalim | 70% | |
| Amai Proteins | 68% |
Ambrosia Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 10, 2024 |
Ambrosia Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BVF Partners L.P. | Series A |
| Boulder Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 75% MoM, from 733 to 1.3K.
- Jun 18, 2026
Monthly visitors increased 50% MoM.
Ambrosia Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ambrosia Bio's valuation, stock price, and market status.
Is Ambrosia Bio a public or private company?
Ambrosia Bio is a private company.
What is the current stock price of Ambrosia Bio?
Ambrosia Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Ambrosia Bio worth (valuation)?
Ambrosia Bio's valuation is estimated at $39.8M based on funding round data.
Can I buy Ambrosia Bio stock?
Ambrosia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ambrosia Bio's last funding round?
Ambrosia Bio's most recent funding round was Series B on December 10, 2024.
Who are the main investors in Ambrosia Bio?
Key investors in Ambrosia Bio include Redmile Group, Blue Owl Capital, Deep Track Capital, BVF Partners L.P., Boulder Ventures.
Will Ambrosia Bio IPO soon?
No public IPO plans have been announced for Ambrosia Bio.
How can I track Ambrosia Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ambrosia Bio's secondary market activity and sign up for updates.